Open AccessP1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T‐CELL PROLYMPHOCYTIC LEUKEMIA (T‐PLL)
Author(s) -
Kadia T.,
Ravandi F.,
Borthakur G.,
Jabbour E.,
MontalbanBravo G.,
Adewale L.,
Pierce S.,
Lacke C.,
Brandt M.,
Short N.,
Jain N.,
Burger J.,
Ferrajoli A.,
Wierda W.,
Kantarjian H.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847640.27266.62
Subject(s) - medicine , alemtuzumab , prolymphocytic leukemia , oncology , gastroenterology , surgery , transplantation , leukemia , chronic lymphocytic leukemia